Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Detalles Bibliográficos
Main Authors:	Payel Kundu, Ines L. Paraiso, Jaewoo Choi, Cristobal L. Miranda, Chrissa Kioussi, Claudia S. Maier, Gerd Bobe, Jan F. Stevens, Jacob Raber
Formato:	Artigo
Idioma:	English
Publicado:	The Company of Biologists 2022-11-01
Series:	Disease Models & Mechanisms
Subjects:	western diet hippocampus water maze ceramides diacylglycerols farnesoid x receptor
Acceso en liña:	http://dmm.biologists.org/content/15/11/dmm049820

Títulos similares

Theabrownin alleviates nonalcoholic fatty liver disease by inhibiting the intestinal farnesoid X receptor–ceramide axis
por: Jieyi Wang, et al.
Publicado: (2024-07-01)

ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways
por: Payel Kundu, et al.
Publicado: (2022-10-01)

Changes in Plasma Bioactive Lipids and Inflammatory Markers during a Half-Marathon in Trained Athletes
por: Melania Gaggini, et al.
Publicado: (2021-05-01)

A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice
por: Stephanie Mourad, et al.
Publicado: (2024-03-01)

Human Brain Lipidomics: Investigation of Formalin Fixed Brains
por: Aaron W. Beger, et al.
Publicado: (2022-06-01)

Effects of Fish Oil and Grape Seed Extract Combination on Hepatic Endogenous Antioxidants and Bioactive Lipids in Diet-Induced Early Stages of Insulin Resistance in Rats
por: Núria Taltavull, et al.
Publicado: (2020-06-01)

Two Different Phospholipases C, Isc1 and Pgc1, Cooperate To Regulate Mitochondrial Function
por: Maria Balazova, et al.
Publicado: (2022-12-01)

Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane
por: Gergana Deevska, et al.
Publicado: (2021-05-01)

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
por: Hongshan Li, et al.
Publicado: (2022-08-01)

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization
por: Thiranut Jaroonwitchawan, et al.
Publicado: (2023-01-01)

Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota
por: Annika Wahlström, et al.
Publicado: (2017-02-01)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
por: Hideki Mori, et al.
Publicado: (2022-07-01)

Effect of a Farnesoid X-receptor Agonist on Postprandial Lipemia in Rats Fed a Supraphysiological Fat Dozes
por: Yu. N. Alekhin, et al.
Publicado: (2023-05-01)

Imaging the early stages of phospholipase C/sphingomyelinase activity on vesicles containing coexisting ordered-disordered and gel-fluid domains[S]
por: Maitane Ibarguren, et al.
Publicado: (2011-04-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017-12-01)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: Jianglian She, et al.
Publicado: (2022-01-01)

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
por: Joana Torres, et al.
Publicado: (2017-10-01)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
por: Sharon Manley, et al.
Publicado: (2015-03-01)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
por: Ewa Harasim-Symbor, et al.
Publicado: (2020-04-01)

Phospholipases and Membrane Curvature: What Is Happening at the Surface?
por: María Laura Fanani, et al.
Publicado: (2023-02-01)

Punicalagin alleviates hypercholesterolemia in mice through modulating farnesoid X receptor signaling and modulating gut microbiota
por: Huanhuan Liu, et al.
Publicado: (2025-01-01)

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
por: Jiangtao Fu, et al.
Publicado: (2024-05-01)

Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway
por: Yang Fan, et al.
Publicado: (2023-11-01)

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis
por: Michael Trauner, et al.
Publicado: (2023-03-01)

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
por: Vahid Jamshidi, et al.
Publicado: (2021-11-01)

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension
por: John D. Imig
Publicado: (2023-06-01)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
por: Shan Cao, et al.
Publicado: (2021-04-01)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
por: Yuxiang Qiu, et al.
Publicado: (2023-09-01)

Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin
por: Daniele Galatolo, et al.
Publicado: (2024-06-01)

Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA
por: Longying Jiang, et al.
Publicado: (2023-01-01)

Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway
por: Shu Feng, et al.
Publicado: (2022-08-01)

Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells
por: Bin Wu, et al.
Publicado: (2019-11-01)

Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
por: Sharon Manley, et al.
Publicado: (2014-01-01)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
por: Lai Peng, et al.
Publicado: (2016-09-01)

Computational study of novel natural agonists targeting farnesoid X receptor
por: Xindan Hu, et al.
Publicado: (2024-07-01)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
por: Peijie Wu, et al.
Publicado: (2021-12-01)

Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane–X–Receptor
por: Zhong-Ping Jiang, et al.
Publicado: (2018-12-01)

The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
por: Kemp M. Anderson, et al.
Publicado: (2021-11-01)

TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
por: Berggren-Söderlund Maria, et al.
Publicado: (2011-11-01)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
por: Mengjiao Zhou, et al.
Publicado: (2022-10-01)